To treat or not to treat?
Millions Of Decisions A Day. Let's Make Them Better.
MeMed BV™ - a pioneering test for distinguishing between bacterial and viral infections that relies on the most accurate detection system - the body's immune system. MeMed BV™ aims to support physicians in making better informed antibiotic treatment decisions and tackling antimicrobial resistance - one of the biggest healthcare challenges of our time.
The test: MeMed BV™
We are applying machine learning to the complex signaling of the world's most accurate diagnostic system, crafted by nature – the immune system. Our pipeline of pioneering tests addresses key clinical challenges in infectious diseases and inflammatory disorders.
In the news
MeMed Co-Founder & CEO, Dr. Eran Eden presented a Lightning Talk at BARDA's Industry Day, highlighting MeMed’s technology which profiles the host-immune response at the point-of-need.
If you are a top tier professional and a team player we would be happy to hear from you. Check out our current open positions.